Schedule 13D ownership disclosure

IO BIOTECH INC

Common Stock, par value $0.001 per share · CUSIP: 449778109

Event date: 2026-01-21

Filing-level shares
2,469,135.00
Percent of class
3.3%
  • Novo Holdings A/SReported CIK 0001388325

    Shares: 2,469,135.00 · Class: 3.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001388325-26-000003
Form type
SCHEDULE 13D/A
Filer
IO Biotech, Inc.
CIK
CIK 1865494
Filed
Jan 23, 2026
Reporting period
Jan 21, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub